IFP Advisors’s Akebia Therapeutics AKBA Stock Holding History

IFP Advisors’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$40	Sell	44 -122	-73%	-$131	﹤0.01%	5078
2026 Q2	$189	Buy	+166	New	+$198	﹤0.01%	4859
2026 Q1	–	Sell	-52	Closed	-$84	–	5020
2025 Q4	$84	Buy	52 +9	+21%	+$19	﹤0.01%	4626
2025 Q3	$117	Buy	+43	New	+$143	﹤0.01%	4517
2025 Q2	–	Hold	0	–	–	–	3345
2021 Q4	–	Sell	-152	Closed	-$1K	–	3376
2021 Q3	$1K	Buy	152 +50	+49%	+$143	﹤0.01%	2966
2021 Q2	$0	Buy	+102	New	+$343	﹤0.01%	3049
2020 Q4	–	Sell	-47	Closed	-$137	–	2927
2020 Q3	$0	Buy	+47	New	+$412	﹤0.01%	2833
2018 Q3	–	Sell	-28	Closed	–	–	3804
2018 Q2	$0	Sell	28 -400	-93%	-$4K	﹤0.01%	3856
2018 Q1	$6K	Hold	428	–	–	﹤0.01%	3044
2017 Q4	$6K	Buy	428 +400	+1,429%	+$6.63K	﹤0.01%	3090
2017 Q3	$1K	Hold	28	–	–	﹤0.01%	3865
2017 Q2	$0	Hold	28	–	–	﹤0.01%	4061
2017 Q1	$0	Hold	28	–	–	﹤0.01%	3966
2016 Q4	$0	Hold	28	–	–	﹤0.01%	3958
2016 Q3	$0	Buy	+28	New	+$238	﹤0.01%	3884
2016 Q1	–	Sell	-77	Closed	-$1K	–	2371
2015 Q4	$1K	Buy	+77	New	+$786	﹤0.01%	3470

Other funds holding AKBA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

PFG Private Wealth Management Lutz, Florida $236M AUM 9.86% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Unified Investment Management Atlanta, Georgia $114M AUM 22.27% 1-Year Est. Return

IWN

Independent Wealth Network Urbandale, Iowa $397M AUM 20.36% 1-Year Est. Return

Legacy Private Trust Neenah, Wisconsin $1.83B AUM 13% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 63.53% 1-Year Est. Return

Northern Lights Advisors Seattle, Washington $192M AUM 14.28% 1-Year Est. Return

IFP Advisors's AKBA Position: Q3 2026 in Review

IFP Advisors reduced its Akebia Therapeutics (AKBA) stake by 73% in Q3 2026, selling an estimated $131 and leaving 44 shares worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #5078.

IFP Advisors first reported a position in AKBA in Q4 2015 and has held it in 16 quarters since. The position peaked at $6K in Q1 2018. 24 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.

IFP Advisors held 44 shares of Akebia Therapeutics worth $40 as of Q3 2026.
IFP Advisors sold 122 Akebia Therapeutics shares in Q3 2026, an estimated $131.
Akebia Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5078 holding.
IFP Advisors first reported a position in Akebia Therapeutics in Q4 2015 and has held it in 16 quarters since.
IFP Advisors's Akebia Therapeutics position peaked at $6K in Q1 2018.
24 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.